Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination Life Science Investing
Trip to Treatment: Lobe Sciences CEO Touts Targeted Low Dosing for Better Patient Outcomes Pharmaceutical Investing
Bristol Myers Squibb Presents Data from CheckMate -76K Showing Opdivo Reduced the Risk of Recurrence or Death by 58% Versus Placebo in Patients with Completely Resected Stage IIB or IIC Melanoma Pharmaceutical Investing
Jamieson Wellness Inc. Announces Date of Third Quarter 2022 Financial Results and Conference Call Life Science Investing
Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022 Life Science Investing
Gilead Presents Real-World and Long-Term Data From HIV Research Programs at HIV Glasgow 2022 Pharmaceutical Investing
Merck and the Bill & Melinda Gates Medical Research Institute Announce Licensing Agreement for Novel Tuberculosis Antibiotic Candidates Life Science Investing
Kite's Yescarta First CAR T-cell Therapy to Receive European Marketing Authorization for Use in Second-Line Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma Pharmaceutical Investing
AbbVie Vice Chairman of External Affairs and Chief Legal Officer Laura J. Schumacher to Retire Pharmaceutical Investing
